Solid Biosciences Inc. SLDB Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Solid Biosciences Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Solid Biosciences Inc.'s financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Solid Biosciences Inc.'s financing cash flow?
- Solid Biosciences Inc. (SLDB) reported financing cash flow of $239.03M in Q1 2026.
- How has Solid Biosciences Inc.'s financing cash flow changed year-over-year?
- Solid Biosciences Inc.'s financing cash flow increased by 26.0% year-over-year, from $189.73M to $239.03M.
- What is the long-term trend for Solid Biosciences Inc.'s financing cash flow?
- Over 3 years (2021 to 2025), Solid Biosciences Inc.'s financing cash flow has grown at a 13.2% compound annual growth rate (CAGR), from $135.22M to $196.05M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.